Skip to content
Screener

PROCEPT BioRobotics Corporation PRCT Q2 2026 earnings

Reported August 4, 2026 · After market close

Revenue$94.5MBeat by $1.7M
EPS-$0.47Miss by $0.01
Revenue estimate$92.8M
EPS estimate-$0.46
“This was an important quarter for PROCEPT as we continued to strengthen the foundation of our business for long-term growth. We delivered 19% revenue growth, achieved record HYDROS placements, demonstrated continued pricing discipline, executed a more robust replacement strategy and completed the commercial realignment that positions us to execute more effectively going forward. Importantly, HYDROS accounts continue to perform well-procedures in the second quarter of 2026 were significantly higher per HYDROS account as compared to our legacy Aquabeam systems.”
Larry Wood

Next report

Nov 3, 2026 (in 2 months)
Revenue estimate$101.1M
EPS estimate-$0.39

Financials

Q2 2026

Income statement

See full
Revenue$94.5M+19.3%
Gross profit$62.4M+20.5%
Operating income-$27.4M-23.4%
Net income-$26.9M-37.2%
EPS (diluted)-$0.47-34.3%

Balance sheet

See full
Cash & equivalents$11.4M-96.3%
Total debt$77.5M-2.4%
Total equity$340.1M-11.9%
Total assets$479.4M-6.6%

Cash flow

See full
Operating cash flow-$19.3M-28.0%
CapEx$3.0M+5.4%
Free cash flow-$22.2M-24.4%

Valuation & ratios

Valuation

as of 09/16/26
See full
Market cap$1.11B-30.0%
Enterprise value$1.17B—
P/S3.3×—

Profitability

See full
Gross margin64.2%0.0pp
Operating margin-33.9%+0.5pp
Net margin-32.5%+2.2pp
FCF margin-25.2%-4.6pp

Returns & leverage

See full
Return on equity-30.2%+5.2pp
Debt / equity0.2×0.0×
Current ratio6.5×-2.7×

Segments

By product

See full
Handpieces and other consumables$55.2M+12.3%
System sales and leases$32.5M—
Service$6.8M+36.1%

FAQ

When did PROCEPT BioRobotics Corporation report Q2 2026 earnings?
PROCEPT BioRobotics Corporation (PRCT) reported Q2 2026 earnings on August 4, 2026 after market close.
What were PROCEPT BioRobotics Corporation's Q2 2026 revenue and EPS?
PROCEPT BioRobotics Corporation reported revenue of $94.5M and eps of $-0.47 for Q2 2026.
Did PROCEPT BioRobotics Corporation beat estimates in Q2 2026?
Revenue beat the consensus estimate of $92.8M by $1.7M. EPS missed the consensus estimate of $-0.46 by $0.01.
How did PROCEPT BioRobotics Corporation's Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 19.3% from $79.2M a year earlier and eps declined 34.3% from $-0.35.
Where can I find PROCEPT BioRobotics Corporation's Q2 2026 SEC filings?
You can read the 8-K earnings release (0001588978-26-000028) and the 10-Q periodic report (0001588978-26-000030) directly on SEC EDGAR. The filing index links above go to sec.gov.